IGF2BP3 anticorps (AA 101-230)

N° du produit ABIN674814

Détail du produit anti-IGF2BP3 anticorps

Antigène: IGF2BP3 (Insulin-Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3))

Épitope: AA 101-230

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp IGF2BP3 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro))

Réactivité croisée: Humain, Souris, Rat

Homologie: Dog,Horse

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human Insulin-like growth factor 2 mRNA-binding protein 3

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur IGF2BP3

Antigène: IGF2BP3 (Insulin-Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3))

Autre désignation: IGF2BP3 (IGF2BP3 Produits)

Synonymes: anticorps CT98, anticorps IMP-3, anticorps IMP3, anticorps KOC1, anticorps VICKZ3, anticorps Ab2-255, anticorps RGD1306512, anticorps imp3, anticorps koc1, anticorps vera, anticorps imp-3, anticorps vg1rbp, anticorps vickz3, anticorps 2610101N11Rik, anticorps AA522010, anticorps AL022933, anticorps AU045931, anticorps Koc13, anticorps Neilsen, anticorps mimp3, anticorps dvr1rbp, anticorps wu:fb79c12, anticorps wu:fe06h09, anticorps zVg1RBP, anticorps B3, anticorps IGF2 mRNA-binding protein 3-B, anticorps IMP, anticorps IMP-3-B, anticorps Vg1 RBP-B, anticorps Vg1-RBP, anticorps igf2bp3, anticorps igf2bp3-a, anticorps igf2bp3-b, anticorps IGF2 mRNA-binding protein 3-A, anticorps IMP-3-A, anticorps Vg1 RBP-A, anticorps vera-A, anticorps insulin like growth factor 2 mRNA binding protein 3, anticorps insulin-like growth factor 2 mRNA binding protein 3, anticorps insulin like growth factor 2 mRNA binding protein 3 S homeolog, anticorps insulin like growth factor 2 mRNA binding protein 3 L homeolog, anticorps IGF2BP3, anticorps Igf2bp3, anticorps igf2bp3, anticorps igf2bp3.S, anticorps igf2bp3.L

Sujet:

Synonyms: KOC, CT98, IMP3, KOC1, IMP-3, VICKZ3, Insulin-like growth factor 2 mRNA-binding protein 3, IGF2 mRNA-binding protein 3, IGF-II mRNA-binding protein 3, KH domain-containing protein overexpressed in cancer, hKOC, VICKZ family member 3, IGF2BP3

Background: RNA-binding factor that may recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation. Binds to the 3'-UTR of CD44 mRNA and stabilizes it, hence promotes cell adhesion and invadopodia formation in cancer cells. Binds to beta-actin/ACTB and MYC transcripts. Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs.

ID gène: 10643

UniProt: O00425